The FDA announced on April 30, 2013, that Hospira Inc. voluntarily recalled Dobutamine Injection Bags due to a lack of assurance of sterility caused by leaking primary containers. The agency issued recall number D-502-2013 for the affected product.
How to tell if you have it
- Brand: Hospira
- Product: DOBUTamine in 5% Dextrose Injection, USP, 250 mg Total, 1000 mcg/mL 250 mL bag
- NDC: 0409-2346-32
- Lot: 11-309-KL
The hazard
The recall addresses a confirmed report of leaking in the primary container, which results in a lack of assurance of sterility for the Dobutamine Injection Bags.
Context
GovInfoNow's records show Hospira Inc. has 108 other recalls on record since April 5, 2012. Other recent recalls include a 2017-04-21 recall for hair particulates in syringes and a 2016-11-01 recall for broken ampule tips risking infection. Similar product recalls include Reliance's June 24, 2026 sterility risk recall, Fresenius Kabi's March 11, 2026 lack of sterility assurance recall, and Teva's March 17, 2026 sterility risk recall.